|
TGFBR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.824700E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.472400E-01 |
| Normal-vs-Stage2 |
2.159900E-02 |
| Normal-vs-Stage3 |
4.11249999610064E-08 |
| Normal-vs-Stage4 |
1.99690000091124E-08 |
| Stage1-vs-Stage2 |
2.481700E-02 |
| Stage1-vs-Stage3 |
1.59760005224996E-09 |
| Stage1-vs-Stage4 |
4.27080004694602E-09 |
| Stage2-vs-Stage3 |
1.413990E-01 |
| Stage2-vs-Stage4 |
6.093800E-02 |
| Stage3-vs-Stage4 |
4.658600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.037250E-03 |
| Normal-vs-AfricanAmerican |
3.570400E-02 |
| Normal-vs-Asian |
6.921200E-01 |
| Caucasian-vs-AfricanAmerican |
6.542000E-01 |
| Caucasian-vs-Asian |
7.857600E-01 |
| AfricanAmerican-vs-Asian |
7.214600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.162800E-04 |
| Normal-vs-Female |
3.929600E-02 |
| Male-vs-Female |
1.359970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.270200E-02 |
| Normal-vs-Age(41-60Yrs) |
5.259700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.229130E-04 |
| Normal-vs-Age(81-100Yrs) |
7.007000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.906600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.172400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.975600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.700400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.114010E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.041600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.857800E-02 |
| Normal-vs-Grade 2 |
7.113400E-01 |
| Normal-vs-Grade 3 |
5.79929999577899E-08 |
| Normal-vs-Grade 4 |
5.92180005032361E-09 |
| Grade 1-vs-Grade 2 |
2.431500E-02 |
| Grade 1-vs-Grade 3 |
2.156400E-03 |
| Grade 1-vs-Grade 4 |
8.172100E-04 |
| Grade 2-vs-Grade 3 |
1.03830000153238E-08 |
| Grade 2-vs-Grade 4 |
3.19610005128368E-09 |
| Grade 3-vs-Grade 4 |
7.255900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.491000E-01 |
| Normal-vs-ccB subtype |
1.02869999962785E-07 |
| ccA subtype-vs-ccB subtype |
9.61519752706863E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.647900E-04 |
| Normal-vs-N1 |
8.603400E-03 |
| N0-vs-N1 |
1.368390E-01 |
|
|
